Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
83
PharmaCompass offers a list of Telotristat Etiprate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Telotristat Etiprate manufacturer or Telotristat Etiprate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Telotristat Etiprate manufacturer or Telotristat Etiprate supplier.
A Lx1606 Hippurate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lx1606 Hippurate, including repackagers and relabelers. The FDA regulates Lx1606 Hippurate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lx1606 Hippurate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lx1606 Hippurate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Lx1606 Hippurate supplier is an individual or a company that provides Lx1606 Hippurate active pharmaceutical ingredient (API) or Lx1606 Hippurate finished formulations upon request. The Lx1606 Hippurate suppliers may include Lx1606 Hippurate API manufacturers, exporters, distributors and traders.
click here to find a list of Lx1606 Hippurate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Lx1606 Hippurate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Lx1606 Hippurate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Lx1606 Hippurate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Lx1606 Hippurate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Lx1606 Hippurate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Lx1606 Hippurate suppliers with NDC on PharmaCompass.
Lx1606 Hippurate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lx1606 Hippurate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Lx1606 Hippurate GMP manufacturer or Lx1606 Hippurate GMP API supplier for your needs.
A Lx1606 Hippurate CoA (Certificate of Analysis) is a formal document that attests to Lx1606 Hippurate's compliance with Lx1606 Hippurate specifications and serves as a tool for batch-level quality control.
Lx1606 Hippurate CoA mostly includes findings from lab analyses of a specific batch. For each Lx1606 Hippurate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lx1606 Hippurate may be tested according to a variety of international standards, such as European Pharmacopoeia (Lx1606 Hippurate EP), Lx1606 Hippurate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lx1606 Hippurate USP).
